Biologic API CDMO Benchmarking for New & Emerging Biopharma: Increased Investment and Presence of Start-Ups Galvanizes Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biologic API CDMO Benchmarking for New & Emerging Biopharma” report has been added to ResearchAndMarkets.com’s offering.

Biological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma landscape within the biologics space. This analysis will help new and emerging biopharma companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.

The publisher understands the need for a deeper dive regarding the new and emerging biopharma landscape. This report provides pharmaceutical companies and contract manufacturers comprehensive analysis of current outsourcing trends and practices, CMO selection drivers, and CMO perceptions and interactions specific to the new and emerging audience. Findings are based on 119 service encounters from 45 respondents who have been involved in outsourced large molecule API projects in the past 18 months.

What you will learn:

New and Emerging Drug Developers:

Uncover which CMO attributes drive outsourcing partner selection for outsourced large molecule API manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers

Gain insight into CMO customer loyalty, based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience

Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs

Contract Manufacturers:

Understanding your company’s competitive positioning and market awareness, and use this information to develop targeted messaging to new and emerging biopharma companies

Gain insight into drug developers’ outsourcing preferences and practices when it comes to CMO selection and CMO preference for outsourced large molecule API manufacturing

Major Topics:

Outsourcing Philosophies and Practices

CMO Selection Drivers

CMO Perceptions and Interactions

Study Data

Demographics

Key Topics Covered:

Copyright and Usage Guidelines

How to Use this Report

Analysis Note: Outsourcing Requirement

Introduction

Methodology

Respondent Demographics and Qualifications

Major Sections

Outsourcing Philosophies and Practices

Primary Section Takeaways

Outsourced Manufacturing Activities

Outsourcing Drivers

Preferred Providers

Number of Preferred Providers

Outsourcing Models

Large Molecule Product Offering

Large vs Small Molecule Outsourcing

CMO Selection Drivers

Primary Section Takeaways

Most Important CMO Attributes

CMO Attributes Gaining Importance

CMO Perceptions and Interactions

Primary Section Takeaways

CMO Familiarity

CMO Leaders – Unprompted

CMO Leaders – Prompted

Received Proposals

CMO Use

CMO Preference

CMO Preference Among Users

CMO Cost Perceptions

Summary Table

CMO Loyalty

Study Data

Outsourced Manufacturing Activities

Outsourcing Drivers

Use of Preferred Providers

Number of Preferred Providers

Outsourcing Models

Large Molecule Product Offering

Large vs Small Molecule Outsourcing

CMO Selection Attributes

CMO Selection Attributes Gaining Importance

CMO Familiarity

CMO Leaders – Unprompted

Other Responses (2%)

CMO Leaders – Prompted

Received Proposals

CMO Use

CMO Preference

CMO Cost Perceptions

Demographics

Company Type

Headquarters Location

Office Location

Job Title

Decision-making Responsibility

Biologic Drug Substance Outsourcing

Contract Manufacturing Responsibilities

Involvement in Outsourced Manufacturing

Contract Manufacturing Involvement

Years of Industry Experience

For more information about this report visit https://www.researchandmarkets.com/r/qigsa5

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.